Cargando…

Application of the American Thyroid Association Risk Assessment in Patients with Differentiated Thyroid Carcinoma in a German Population

Background: The American Thyroid Association (ATA) uses criteria to assess the risk for persistent disease in differentiated thyroid carcinoma (DTC) after radioiodine therapy (RAI). There are no data available showing that this classification can be adopted unadjusted by Germany. Aim: The aim of our...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eilsberger, Friederike, Kreissl, Michael C., Reiners, Christoph, Holzgreve, Adrien, Luster, Markus, Pfestroff, Andreas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045624/ https://www.ncbi.nlm.nih.gov/pubmed/36979890 http://dx.doi.org/10.3390/biomedicines11030911

Ejemplares similares

Perioperative diagnostics of patients referred for radioiodine therapy of differentiated thyroid carcinoma: referral center experience in an iodine-insufficient country
por: Eilsberger, Friederike, et al.
Publicado: (2020)

Prostate-Specific Membrane Antigen in Anaplastic and Poorly Differentiated Thyroid Cancer—A New Diagnostic and Therapeutic Target?
por: Wächter, Sabine, et al.
Publicado: (2021)

Second primary malignancies induced by radioactive iodine treatment of differentiated thyroid carcinoma — a critical review and evaluation of the existing evidence
por: Reinecke, Maximilian J., et al.
Publicado: (2022)

Real-Life Performance of F-18-FDG PET/CT in Patients with Cervical Lymph Node Metastasis of Unknown Primary Tumor
por: Eilsberger, Friederike, et al.
Publicado: (2022)

Questions and Controversies in the Clinical Application of Tyrosine Kinase Inhibitors to Treat Patients with Radioiodine-Refractory Differentiated Thyroid Carcinoma: Expert Perspectives
por: Verburg, Frederik A., et al.
Publicado: (2021)

Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment – initial experience
por: Werner, R. A., et al.
Publicado: (2016)

Individualized multimodal treatment strategy for anaplastic thyroid carcinoma—Case report of long-term remission and review of literature
por: Eckhardt, S., et al.
Publicado: (2016)

2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
por: Lebbink, Chantal A, et al.
Publicado: (2022)

Editorial: Differentiated Thyroid Cancer - Risk Adapted Therapy, Genetic Profiling and Clinical Staging
por: Reiners, Christoph, et al.
Publicado: (2021)

Editorial: Radiation as Risk Factor, Early Diagnosis, Therapy, and Follow-up of Differentiated Thyroid Cancer
por: Reiners, Christoph, et al.
Publicado: (2021)

Mutation-based, short-term “neoadjuvant” treatment allows resectability in stage IVB and C anaplastic thyroid cancer
por: Maurer, Elisabeth, et al.
Publicado: (2023)

Diagnostic Impact of Dual-Time PET/CT with (68)Gallium-PSMA in Prostate Cancer and (68)Gallium-DOTATOC in Neuroendocrine Tumors
por: Librizzi, Damiano, et al.
Publicado: (2023)

Clinical Experiences with Radiation Induced Thyroid Cancer after Chernobyl
por: Reiners, Christoph
Publicado: (2011)

The Importance of the 2015 American Thyroid Association Guidelines for Adults with Thyroid Nodules and Differentiated Thyroid Cancer in Minimising Overdiagnosis and Overtreatment of Thyroid Carcinoma
por: Leite, Valeriano
Publicado: (2018)

Ultrasound Assessment of Autonomous Thyroid Nodules before and after Radioiodine Therapy Using Thyroid Imaging Reporting and Data System (TIRADS)
por: Schenke, Simone Agnes, et al.
Publicado: (2020)

Molecular Theranostics in Radioiodine-Refractory Differentiated Thyroid Cancer
por: Petranović Ovčariček, Petra, et al.
Publicado: (2023)

Pediatric papillary thyroid cancer: current management challenges
por: Verburg, Frederik A, et al.
Publicado: (2016)

Applicability of Adults 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines for Postoperative Risk Stratification and Postradioiodine Treatment Dynamic Risk Stratification in Pediatric Population
por: Singh, Shashank Shekhar, et al.
Publicado: (2022)

Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma
por: Teng, Lianghong, et al.
Publicado: (2017)

Etiopathogenesis of Differentiated Thyroid Carcinomas
por: Makazlieva, Tanja, et al.
Publicado: (2016)

Multicentricity in the thyroid differentiated carcinoma
por: Chagas, José Francisco Salles, et al.
Publicado: (2015)

Kinase-Inhibitors in Iodine-Refractory Differentiated Thyroid Cancer—Focus on Occurrence, Mechanisms, and Management of Treatment-Related Hypertension
por: Kaae, Anne Christine, et al.
Publicado: (2021)

Update to the College of American Pathologists Reporting on Thyroid Carcinomas
por: Ghossein, Ronald
Publicado: (2009)

The Effect of ThyroidߚStimulating Hormone on Stage of Differentiated Thyroid Carcinoma
por: Soleimanisardoo, Laya, et al.
Publicado: (2021)

Does chronic lymphocytic thyroiditis influence the staging of differentiated thyroid carcinoma?
por: Nemetz, Marcos Antonio, et al.
Publicado: (2015)

Impact of the new guidelines of the American Thyroid Association on the treatment of the differentiated thyroid tumor in an Italian center with medium-high volume thyroid surgery
por: Bove, Aldo, et al.
Publicado: (2019)

Is new American Thyroid Association risk classification for hereditary medullary thyroid carcinoma applicable to Chinese patients? A single-center study
por: Zhang, Xiwei, et al.
Publicado: (2017)

Comparison of Clinical and Ultrasonographic Features of Poorly Differentiated Thyroid Carcinoma and Papillary Thyroid Carcinoma
por: Zhang, Bo, et al.
Publicado: (2016)

The Expression of Twist in Differentiated Thyroid Carcinomas
por: CALANGIU, CRISTINA MARIANA, et al.
Publicado: (2014)

Genomic Characterization of Differentiated Thyroid Carcinoma
por: Song, Young Shin, et al.
Publicado: (2019)

2022 ETA Consensus Statement: What are the indications for post-surgical radioiodine therapy in differentiated thyroid cancer?
por: Pacini, Furio, et al.
Publicado: (2021)

Application of intensity-modulated radiotherapy in unresectable poorly differentiated thyroid carcinoma
por: Xue, Fen, et al.
Publicado: (2016)

MON-508 Clinicopathological Features of Papillary Thyroid Cancer After Fukushima and Chernobyl Accidents
por: Drozd, Valentina, et al.
Publicado: (2020)

An Unexpected Finding of Poorly Differentiated Thyroid Carcinoma in a Toxic Thyroid Nodule
por: Yuang, Kimberly, et al.
Publicado: (2023)

Lenvatinib for the Treatment of Radioiodine-Refractory Differentiated Thyroid Cancer: Treatment Optimization for Maximum Clinical Benefit
por: Wirth, Lori J, et al.
Publicado: (2022)

Differentiated thyroid cancer patients potentially benefitting from postoperative I-131 therapy: a review of the literature of the past decade
por: Verburg, Frederik A., et al.
Publicado: (2019)

A Search for Causes of Rising Incidence of Differentiated Thyroid Cancer in Children and Adolescents after Chernobyl and Fukushima: Comparison of the Clinical Features and Their Relevance for Treatment and Prognosis
por: Drozd, Valentina, et al.
Publicado: (2021)

Follicular thyroid carcinoma in a child presenting as autonomously functioning thyroid nodule
por: Joshi, Kiranjit, et al.
Publicado: (2015)

Lobectomy and completion thyroidectomy rates increase after the 2015 American Thyroid Association Differentiated Thyroid Cancer Guidelines update
por: Worrall, Benjamin J, et al.
Publicado: (2023)

Management of Thyroid Eye Disease: A Consensus Statement by the American Thyroid Association and the European Thyroid Association
por: Burch, Henry B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6mqukok0acjpsgff77jtch8i4q